Vir Biotechnology, Inc.
NASDAQ:VIR
9.87 (USD) • At close November 11, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Omzet
| 86.18 | 1,580.472 | 1,087.068 | 67.245 | 0.711 | 0.868 | 0.149 |
| Kosten van de omzet
| 22.216 | 146.319 | 65.865 | 301.579 | 148.472 | 100.229 | 62.512 |
| Brutowinst
| 63.964 | 1,434.153 | 1,021.203 | -234.334 | -147.761 | -99.361 | -62.363 |
| Brutowinstmarge
| 0.742 | 0.907 | 0.939 | -3.485 | -207.821 | -114.471 | -418.544 |
| Onderzoek- en ontwikkelingskosten
| 550.92 | 474.648 | 448.006 | 302.411 | 148.472 | 100.229 | 62.512 |
| Algemene en administratieve kosten
| 0 | 0 | 0 | 70.937 | 37.598 | 29.131 | 21.693 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 174.049 | 161.762 | 160.793 | 70.937 | 37.598 | 29.131 | 21.693 |
| Overige kosten
| -8.991 | -35.325 | -8.347 | -9.123 | -7.38 | -0.212 | 0.083 |
| Bedrijfskosten
| 724.969 | 601.085 | 600.452 | 364.225 | 178.69 | 119.56 | 81.646 |
| Bedrijfsresultaat
| -661.005 | 833.068 | 276.891 | -296.98 | -177.979 | -118.692 | -81.497 |
| Bedrijfsresultaat ratio
| -7.67 | 0.527 | 0.255 | -4.416 | -250.322 | -136.742 | -546.96 |
| Totaal overige inkomsten en kosten netto
| 32.811 | -78.788 | 272.911 | -1.631 | 3.45 | -0.212 | 0.083 |
| Inkomen voor belasting
| -628.194 | 754.28 | 549.802 | -298.611 | -174.529 | -116.364 | -80.776 |
| Inkomen voor belasting ratio
| -7.289 | 0.477 | 0.506 | -4.441 | -245.47 | -134.06 | -542.121 |
| Belastingkosten
| -13.077 | 238.443 | 21.218 | 0.054 | 0.154 | -0.48 | -10.924 |
| Nettowinst
| -615.061 | 515.837 | 528.584 | -298.665 | -174.683 | -115.884 | -69.852 |
| Nettowinstmarge
| -7.137 | 0.326 | 0.486 | -4.441 | -245.686 | -133.507 | -468.805 |
| WPA (Winst Per Aandeel)
| -4.59 | 3.89 | 4.07 | -2.51 | -1.62 | -1.2 | -0.72 |
| Verwaterde WPA
| -4.59 | 3.83 | 3.96 | -2.51 | -1.62 | -1.2 | -0.72 |
| EBITDA
| -641.554 | 944.208 | 282.702 | -296.98 | -177.979 | -115.936 | -81.065 |
| EBITDA ratio
| -7.444 | 0.597 | 0.26 | -4.416 | -250.322 | -133.567 | -544.06 |